未经证实:抗癫痫药物(ASM)引起的药物过敏反应是患者管理中的主要问题之一。找到不引起过敏反应并且具有可接受的有效性的替代ASM可能是困难的。在这方面,本研究试图调查苯巴比妥和左乙拉西坦在癫痫发作控制治疗儿童中的交叉反应性.
未经批准:本研究是一项前瞻性研究,观察性独立评估者研究。研究了30名对苯巴比妥治疗过敏的癫痫患儿。为了评估药物的交叉反应性,左乙拉西坦代替苯巴比妥控制癫痫发作。六个月内,对患者的任何过敏反应和癫痫发作复发进行了评估.
未经评估:这项研究中53%的儿童是女性。患者平均年龄为42.4个月。在患者随访中,任何患者均未观察到交叉反应性反应。在随访的前六个月,癫痫复发率为30%,在随访的后六个月,随着剂量的增加,下降到10%。
UNASSIGNED:根据这项研究的结果,在由苯巴比妥控制的癫痫儿童中,如果发生对苯巴比妥的过敏反应,左乙拉西坦可用作合适的替代药物。
UNASSIGNED: Pharmaceutical allergic reactions due to antiseizure medications (ASMs) are one of the major concerns in the management of patients. Finding an alternative ASM which does not cause allergic reactions and has acceptable effectiveness can be difficult. In this regard, the present
study attempts to investigate the cross-reactivity between phenobarbital and levetiracetam in children under treatment for seizure control.
UNASSIGNED: The present
study is a prospective, observational independent assessor
study. 30 children with epilepsy who were hypersensitive to phenobarbital therapy were studied. In order to evaluate the cross-reactivity of the drugs, levetiracetam replaced phenobarbital to control seizure. Within 6 months, any allergic reactions and seizure recurrences were evaluated in the patients.
UNASSIGNED: 53 % of the children in this
study were female. The mean age of patients was 42.4 months. In patients\' follow up no cross-reactive responses were observed in any of the patients. Seizure recurrence rate was 30 % in the first six months of follow up that with increasing dosage in the second six months of follow-up, decreased to 10 %.
UNASSIGNED: Based on the results of this
study, in children with epilepsy controlled by phenobarbital if allergic reactions to phenobarbital occur, levetiracetam may be used as a suitable alternative medicine.